TB in Yorkshire and the Humber Dr Simon Padfield 14 th Sept 2007.

Slides:



Advertisements
Similar presentations
Implementing a TB-Control Program in Prisons: The Basics Dr. Mayra Arias.
Advertisements

Implementing NICE guidance
For primary and secondary care settings
Metastatic spinal cord compression
Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
HIV Counselling and Testing
MYCOBACTERIUM BOVIS SULTANETE OF OMAN DR.SAMAH AL-SHARIF HEAD OF VETERINARY QUARANTINE SECTION AT MUSCAT INT. AIRPORT THE REGIONAL SEMINARFOR OIE NATIONAL.
CROYDON TB SERVICE ANNE SMITH Lead TB Nurse Specialist
This presentation will ‘walk’ you through the pathway and guide you on how to use this tool.
Follow-up after training and supportive supervision The IMAI District Coordinator Course.
M. Samarkos TUBERCULOSIS IN GREECE. INTRODUCTION.
429 pharmaceutical care Plan Refa’a AlAjmi. Goal of therpay A goal of therapy is the desired response or endpoint that you and your patient want to achieve.
Fylde Coast Integrated Diabetes Care
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Drug Utilization Review (DUR)
Hallauer 06/20011 Outcome evaluation of an universal hepatitis B immunisation programme Johannes F. Hallauer M.D. Health Systems Research Charité, Humboldt.
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Tuberculosis in the UK 2013 report
Latent Tuberculosis among Displaced Populations Rapid Diagnosis and Control Nikolaou Aristidis MD, MSc.
Moving forward in the diagnosis of infectious diseases in developing countries: a focus on malaria Forum organized by Fondation Mérieux & the Roll Back.
Unit 5: IPT Isoniazid TB Preventive Therapy
Culture Conversion and Self- Administered Therapy in Privately Managed Tuberculosis Patients Melissa Ehman MPH, Jennifer Flood MD MPH, Pennan Barry MD.
1 Meeting with Contacts for TB Assessment. Learning Objectives After this session, participants will be able to: 1.Explain why contact assessments are.
©2007 World Heart Federation … Updated October 2008 Diagnosis and Management of Acute Rheumatic Fever and Rheumatic Heart Disease.
From Pandemic Preparedness to Management: UK experience Professor Lindsey Davies CBE FRCP FFPH National Director of Pandemic Influenza Preparedness.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Epidemiology Tools and Methods Session 2, Part 1.
Screening Implementation: Referral and Follow-up What Do You Do When the Screening Test Is of Concern? Paul H. Lipkin, MD D-PIP Training Workshop June.
Tuberculosis in Ealing. What is TB Tuberculosis, or TB, is a disease caused by a germ (Mycobacterium tuberculosis). TB usually affects the lungs, but.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Tuberculosis Research of INA-RESPOND on Drug-resistant
How Can Communication And Social Mobilization Help the DOTS Strategy? An Outcome Map To Strengthen DOTS Strategy To STOP TB © Johns Hopkins University.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Universal access to TB care what is the challenge, what policy, what is being implemented Cancun 3 December 2009 Léopold BLANC and TBS team TBS/STB/WHO.
Heart Failure: a community-based diagnostic clinic & service
1 Counseling and HIV Testing HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Health Organization The Challenges Facing Tuberculosis Control Blantyre Hospital, Malawi: TB Division, 3 patients per bed.
Beyond Sputum Cups and Four Drugs The Responsibility of the Practicing Clinician in the Community Control of Tuberculosis V. R. Koppaka, MD, PhD Division.
TB, MDR-TB and XDR-TB in South Africa October 2006.
Alzheimer Scotland Dementia Post Diagnostic Support Service Edinburgh January 2014.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
11 Mayview Regional Service Area Plan (MRSAP) Tracking: Supporting Individuals in the Community June 18, 2008.
CANCER IN THE WORKPLACE: HOW EMPLOYERS CAN HELP Lynn Zonakis Principal, The Zonakis Group LLC October 23, 2015.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
StagesOf Assessment Stages Of Assessment. The Stages of Assessment for the Single Assessment Process §Publishing information about services. §Completing.
TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.
ACAT Referral Mechanisms Liverpool/ Fairfield Aged Care Assessment Team Rozina Shekhar CNC Community Aged Care.
NICE Quality Standard 48: Depression in children and young people An audit of adherence to Quality Standards within Camhs Dr. Angela Brennan Principal.
Roundtable. Detection and treatment of TB Andrew Black.
The Strategic Health Authority for London London and TB 4 October 2007 Lynn Altass NHSL Public Health – TB North Central London TB Network Manager.
Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Antibiotic Use on the Postnatal Ward Inching towards NICE Dr R Morris Dr M Pickup Dr S Banerjee Department of Neonatal Medicine, Singleton Hospital, Swansea.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
This is an archived document.
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Find and Treat All Missing Persons with TB
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Mark Lobato, MD Division of TB Elimination
Knowledge gaps in formulating TB Control Policies for Prisons
Achieving World-Class Cancer Outcomes A Strategy for England
Achieving World-Class Cancer Outcomes A Strategy for England
Communicable Disease Surveillance Centre, London
Stroke Protocols Ensure Efficient Patient Intake, Diagnosis, Treatment
Multi-disease diagnostic integration
Presentation transcript:

TB in Yorkshire and the Humber Dr Simon Padfield 14 th Sept 2007

Why prioritise TB? TB is a preventable, curable, transmissible disease rates are increasing inequality issue low costs of intervention avoidance of outbreaks avoidance of MDR cases

Insert Image Comparison UK vs. US England & Wales - 48% increase USA – 53% decrease

Comparison Western Europe, Countries with rate > 9 per 100,000 in 2005

Regional trend

Trend by PCT Insert Image

Migration from high incidence countries

Inequalities UK born vs. non UK born Working age population

Delay from onset of symptoms to start of treatment Complex reasons for delay – inequality issue Overall median delay 69 days – but should be a rapid access service Potential to infect an estimated further 8 people

Treatment outcomes Generally high levels of completion Need to ensure meeting CMO target – transmission is important to avoid!

Outbreaks and incidents

Multi Drug Resistance 5 cases of MDR TB in 2006 in Yorkshire and Humber 51 cases in England, Wales and NI

TB Pathway Refer to TB Specialist Clinician population symptomatic presentation to GP population or occupational screening symptomatic or high risk Correct diagnostic tests administered and interpreted by experienced professional TB suspecte d PaediatricsGUM presentation to other medical speciality Correct clinical and diagnostic investigations and tests administered and interpreted by experienced professional Samples collected and stored appropriately and delivered quickly Immediate referral to appropriate laboratory with relevant experience and facilities where the latest methods are employed to determine diagnosis, infectivity, resistance and strain Diagnosis TB unlikely. Consider alternative diagnosis TB confirmed. Notfiy. TB likely but unconfirmed. Consider treatment and review at 4 weeks. Baseline tests (weigh), commence treatment, minimum monthly clinic visits: weigh, review clinical condition and drug tolerance, review meds re drug sensitivity testing TB Specialist Community Team establish and maintain contact educate, evaluate, monitor, encourage commence contact tracing Screen close, vulnerable and those with high transmission risk with appropriate test by those experienced in test administration and reading. Give tb information to casual contacts Refer <16 to Paediatrics Screen negative Screen positive results communicated quickly and efficiently Presentation & Screening Contact Tracing Diagnosis Treatment and follow-up Cure maintain communication results communicated quickly and efficiently

Next steps TB toolkit workshop Regional taskforce